Cover Image
Read Now

Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department

Evidence-informed recommendations on the use of cardiac troponin for the rapid diagnosis of acute coronary syndrome (ACS) in the emergency department (ED) were developed by the CADTH Health Technology Expert Review Panel (HTERP) to address the following policy questions: 1. Question 1: In light of t...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health March 2013, 2013
Series:CADTH optimal use report
Subjects:
Canada
Acute Coronary Syndrome / Diagnosis
Emergencies
Biomarkers / Blood
Troponin / Blood
Biological Assay / Methods
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02020nam a2200289 u 4500
001 EB002002231
003 EBX01000000000000001165132
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
245 0 0 |a Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department  |h Elektronische Ressource 
260 |a Ottawa (ON)  |b Canadian Agency for Drugs and Technologies in Health  |c March 2013, 2013 
300 |a 1 PDF file (i, 10 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Canada 
653 |a Acute Coronary Syndrome / diagnosis 
653 |a Emergencies 
653 |a Biomarkers / blood 
653 |a Troponin / blood 
653 |a Biological Assay / methods 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH optimal use report 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK361723  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a Evidence-informed recommendations on the use of cardiac troponin for the rapid diagnosis of acute coronary syndrome (ACS) in the emergency department (ED) were developed by the CADTH Health Technology Expert Review Panel (HTERP) to address the following policy questions: 1. Question 1: In light of the discontinuation of the conventional cardiac troponin T assay and the development of high-sensitivity cardiac troponin assays to determine cardiac ischemia in patients presenting in the ED with chest pain, which of the other troponin assays should hospitals adopt? Does one of the troponin assays offer an advantage as compared with the others when used in the ED setting? 2. Question 2: Are there evidence-based strategies available to optimize the use of troponin tests in the ED setting? For a particular troponin test, does one of these strategies result in better outcomes? 

Similar Items